Dna X (SONM) Total Non-Current Liabilities (2018 - 2026)

Dna X's Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• Quarterly Total Non-Current Liabilities fell 87.17% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 87.17% YoY) and the FY2025 annual result came in at $50.5 million, up 15.35% from the prior year.
• Total Non-Current Liabilities was $4.5 million for Q1 2026 at Dna X, down from $50.5 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $50.5 million in Q4 2025 and bottomed at $4.5 million in Q1 2026.
• A 5-year average of $31.0 million and a median of $32.1 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2025 — Total Non-Current Liabilities surged 68.02% — and 2026, when it sank 87.17%.
• Dna X's Total Non-Current Liabilities stood at $32.2 million in 2022, then slipped by 0.2% to $32.1 million in 2023, then soared by 36.06% to $43.7 million in 2024, then grew by 15.35% to $50.5 million in 2025, then slumped by 91.04% to $4.5 million in 2026.
• Business Quant data shows SONM's Total Non-Current Liabilities at $4.5 million in Q1 2026, $50.5 million in Q4 2025, and $39.1 million in Q3 2025.